CBN for Dogs: What Is Cannabinol and Why Is It in Our CBD Night Formula?

When pet owners search for CBN for dogs or ask whether CBD for dogs can support nighttime rest, the answer lies in understanding how specific cannabinoids interact with the endocannabinoid system (ECS), the biological network that governs sleep, relaxation, comfort, and immune function in all mammals.

CBN (cannabinol) is one of the most compelling minor cannabinoids in veterinary wellness today, and at Peak Therapeutics, it was selected for our CBD Night formula (Purple Label) for specific, evidence-based reasons rooted in peer-reviewed science and clinical experience.

This article is a science-backed overview of what CBN is, how CBN for dogs differs from CBD for dogs, what the current research shows about cannabinol and sleep support, how the endocannabinoid system makes CBN effective in pets, and why Peak Therapeutics formulated CBD Night the way we did.

Whether you are a pet owner researching CBD oil for dogs or a veterinarian evaluating cannabinoid nutraceuticals, this guide provides the evidence and clinical context you need.

1. What Is CBN (Cannabinol)? Understanding CBN for Dogs

CBN stands for cannabinol, a naturally occurring cannabinoid found in the hemp plant. Unlike CBD for dogs, which is directly synthesized by the plant, CBN is formed when THC oxidizes over time. As hemp ages and is exposed to heat or light, THC slowly converts into CBN. This process produces a compound with very little to no psychoactive effect, making it safe, non-intoxicating, and well-suited for use in pets.

Notably, CBN holds a significant place in the history of cannabinoid science: it was the first cannabinoid ever isolated by researchers in the 1930s, predating the discovery of both CBD and THC. Despite this long history, it is only in recent years that scientists have begun to systematically explore its full therapeutic potential, particularly in relation to sleep support, relaxation, and comfort in companion animals.

Understanding the distinction between CBN for dogs and CBD for dogs is key to understanding why CBD Night (Purple Label) is a fundamentally different product from standard CBD formulas, not just a different color cap, but a different clinical tool designed for a specific purpose.

2. CBN vs. CBD for Dogs: A Critical Comparison

One of the most important concepts in veterinary cannabinoid medicine, and one that every pet owner considering CBD for pets should understand, is the fundamental difference between CBN and CBD. Both are non-intoxicating cannabinoids derived from hemp, but they serve different clinical roles.

3. What Does CBN Do? The Science of CBN for Dogs

CBN for dogs research is still emerging, as is true of most cannabinoid science, but the early findings are compelling, particularly for sleep and relaxation support. Here is what the current evidence points to:

Sleep Support: CBN has long been associated with sedative properties. Research and clinical observations suggest CBN may support drowsiness and promote longer, more restful sleep cycles, particularly when combined with CBD. A 2024 randomized, double-blind, placebo-controlled human trial found that CBN combined with CBD significantly improved sleep quality scores compared to placebo.

Muscle Relaxation: In addition, studies have indicated that CBN may act as a muscle relaxant, helping ease tension and physical restlessness that can prevent quality sleep in dogs and other companion animals.

Appetite Stimulation: Preclinical studies also suggest CBN may gently stimulate appetite, which can be valuable for pets recovering from illness, surgery, or periods of stress-related appetite suppression.

Comfort and Inflammatory Pathway Support: Similarly, CBN appears to interact with the body’s inflammatory pathways through the endocannabinoid system, potentially contributing to overall physical ease and calm in dogs.

The Entourage Effect with CBD: CBN is believed to work synergistically with CBD for dogs, each amplifying the other’s effects.

This pharmacological synergy, known as the entourage effect, is a core reason why combining them in one formula produces more targeted results than either compound alone. Research has shown that multiple cannabinoid compounds show potential for supporting sleep through ECS interactions, and that CBN may potentiate the effects of other cannabinoids.

4. The Endocannabinoid System: Why CBN Works in Pets

To understand why CBN for dogs is effective, it helps to understand the endocannabinoid system (ECS), the biological network through which all cannabinoids exert their effects. The ECS is present in all mammals, including dogs, cats, and horses.

It is a complex cell-signaling system involving receptors (CB1 and CB2), naturally produced endocannabinoids, and enzymes that regulate a wide range of physiological processes including sleep, mood, comfort, immune response, and appetite.

A 2024 comparative review confirmed that the ECS is conserved across the main species of veterinary interest, with species-specific differences in receptor distribution and cannabinoid metabolism.

Because CBN appears to interact with both CB1 and CB2 receptor types, as well as potentially influencing GABA pathways, an inhibitory neurotransmitter system associated with relaxation and sedation, its effects are specifically relevant to nighttime wellness. In particular, CBN’s receptor interactions align closely with the biological mechanisms of sleep and relaxation, making it a logical and targeted addition to a nighttime formula for dogs.

5. CBN and Sleep Support: What the Research Shows

The area of CBN research that has attracted the most attention is its role in supporting sleep and relaxation. While large-scale controlled veterinary trials specifically on CBN remain limited, as with much of cannabinoid science, the available evidence from preclinical research, human clinical trials, and clinical observation provides compelling scientific grounding.

A 2021 review in Cannabis and Cannabinoid Research examined the historical and emerging evidence around CBN and sleep, noting that while early research attributed sedative properties to CBN, rigorous controlled data was only beginning to accumulate. The review called for further investigation while acknowledging the compound’s longstanding association with relaxation and drowsiness.

Meanwhile, a separate 2021 review in Neurotherapeutics examined the broader effects of cannabinoids on sleep, finding that multiple cannabinoid compounds show potential for supporting sleep through ECS interactions, and that combination approaches (such as CBD + CBN) may be particularly effective.

Furthermore, classical pharmacological research dating to 1975 provided early evidence that CBN may potentiate the sedative effects of THC in human subjects, establishing CBN’s role in the broader pharmacological understanding of cannabinoid interactions and the entourage effect.

6. Why CBN Is in Our CBD Night Formula

When Dr. Gaynor developed the CBD Night (Purple Label) formula, the clinical goal was clear: create a product specifically designed to support rest, calm, and nighttime recovery in pets, not simply a standard CBD oil for dogs with a different label. CBN was chosen as the key complementary cannabinoid for three evidence-based reasons:

1. Its Specific Nighttime Profile: While CBD for dogs provides broad everyday wellness support, CBN is the cannabinoid most closely associated with sedation and relaxation in the scientific literature. Consequently, combining them in CBD Night targets nighttime needs more precisely than CBD alone, addressing sleep, muscle tension, and restlessness together.

2. The Synergistic Entourage Effect: CBD and CBN work better together than in isolation. The entourage effect, where multiple cannabinoids enhance each other’s activity, means the full-spectrum CBD Night formula delivers more complete nighttime support than an isolated CBD product. For this reason, Peak Therapeutics uses CO₂-extracted, full-spectrum hemp to preserve this synergy.

3. Safety in Pets: CBN has a well-established safety profile. It is non-psychoactive and non-toxic, and does not produce the intoxicating effects associated with THC. Dr. Gaynor selected it because it meets the same rigorous clinical safety standards he applies to every Peak Therapeutics formulation. All products are independently third-party lab tested to verify potency and purity.

7. Clinical Perspective: Dr. James S. Gaynor, DACVAA

This transparency is intentional. Dr. Gaynor applies the same evidence standards to nutraceutical formulations that he applies to pharmaceutical decisions in clinical practice. When the science is emerging, Peak Therapeutics says so and explains the clinical reasoning behind every formulation choice. For a full clinical overview of cannabinoid pharmacology in veterinary patients, see: Cannabis Therapy in Veterinary Medicine (Springer, 2021), co-edited and co-authored by Dr. Gaynor.

It is also important to recognize that CBD for dogs and CBN for dogs should be viewed as components of an integrative treatment strategy that may also include rehabilitation therapy, nutritional management, pharmaceutical therapy, and regenerative medicine. Veterinary supervision and appropriate product selection remain essential when incorporating nutraceuticals into clinical care.

8. How CBD Night Fits the Full Peak Therapeutics Product Line

Understanding where CBD Night sits within the broader Peak Therapeutics product family helps pet owners make the best choices for their animals. Every Peak Therapeutics formulation is designed with the endocannabinoid system in mind, with species-specific concentrations, full-spectrum extraction, and targeted cannabinoid combinations.

In practice, many pet owners use the standard Blue/Green Label CBD for dogs during the day for general wellness and then switch to CBD Night in the evening for targeted nighttime support. This combined approach mirrors the multimodal philosophy Dr. Gaynor has applied throughout his clinical career, using targeted tools at the right times rather than a one-size-fits-all approach.

Full product guide and third-party lab results: peaktherapeutics.net

9. How to Use CBD Night for Dogs

CBD Night is designed for evening use, ideally 30 to 60 minutes before your pet’s bedtime, or during periods of expected stress such as thunderstorms, fireworks, travel, or post-procedure recovery.

As always, consult your veterinarian before starting any new supplement, especially if your pet is on other medications or has an underlying health condition. Peak Therapeutics products are independently third-party lab tested; results are available at peaktherapeutics.net.

11. References

The following peer-reviewed sources support the content of this article:

[1] Corroon J. Cannabinol and Sleep: Separating Fact from Fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. doi:10.1089/can.2021.0006

[2] Kaul M, Zee PC, Bhatt AS. Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders. Neurotherapeutics. 2021;18(1):217-227.

[3] Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE. Effects of delta9-tetrahydrocannabinol and cannabinol in man. Pharmacology. 1975;13(6):502-512.

[4] Corroon J, et al. A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. J Clin Psychol. 2024;80(3):652-664.

[5] Silver RJ. The Endocannabinoid System of Animals. Animals (Basel). 2019;9(9):686. doi:10.3390/ani9090686

[6] Gaynor JS, et al. (eds). Cannabis Therapy in Veterinary Medicine: A Complete Guide. Springer, 2021.

[7] Di Salvo A, Chiaradia E, Sforna M, Della Rocca G. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review. Vet Res Commun. 2024;48(5):2915-2941.

[8] Kitts-Morgan SE, et al. Pharmacokinetics of cannabidiol and metabolites after IV and oral administration of a full-spectrum hemp product to beagle dogs. Front Vet Sci. 2025;12.

12. About Dr. James S. Gaynor, DVM, MS, Diplomate ACVAA

Education: BA Biology (The Colorado College), DVM (The Ohio State University), MS Cardiac Physiology (The Ohio State University)

Board Certifications: American College of Veterinary Anesthesiologists (1993), Academy of Integrative Pain Management (2004), Certified CBD Consultant, Cannabinoid Medicine Studies (2020)

Academic Career: Associate Professor and Section Head of Anesthesiology, Colorado State University College of Veterinary Medicine (1992-2003)

Clinical Practice: Medical Director and Staff Anesthesiologist, Peak Performance Veterinary Group, Frisco, CO (2004-2021); Medical Director and Staff Anesthesiologist, Colorado Animal Specialty and Emergency, Boulder, CO (2021-2025/6); Staff Anesthesiologist, Buffalo Mountain Animal Hospital, Dillon, CO (2026-present); Medical Director and Staff Anesthesiologist, Black Dog Veterinary Anesthesia Services, Breckenridge, CO (2026-present)

Editorial Role: Associate Editor, Frontiers in Veterinary Sciences (2025-2026)

Published Books: Co-editor and author of Cannabis Therapy in Veterinary Medicine: A Complete Guide (Springer, 2021), the definitive peer-reviewed academic textbook on veterinary cannabinoid medicine. Lead editor and author of the Handbook of Veterinary Pain Management, 3rd Edition (Mosby/Elsevier, 2015), the gold-standard clinical reference for veterinary pain management.

Research includes a 2025 pharmacokinetic study published in Frontiers in Veterinary Science confirming the bioavailability and safety profile of full-spectrum CBD in dogs.

Peak Therapeutics was founded by Dr. Gaynor to bring the same evidence-based standards applied throughout his academic and clinical career directly to veterinary CBD and nutraceutical products.